Read more: Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study
Read more: Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study
Read more from the original source: Avicanna Announces Exercise and Closing of Over-Allotment Option
Read more here: Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete...
Read the original here: Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
More here: Teligent, Inc. Announces Third Quarter 2020 Results
Read this article: Tauriga Sciences Inc. Approved to be Corporate Exhibitor at 2021 CTIC Capital Pre-J.P. Morgan Healthcare Investment Summit January 9th-10th, 2021
Read more from the original source: Vaxil’s Annual and Special Shareholders Meeting and Update on Exercise of Warrants
Go here to see the original:Tauriga Sciences Inc. Completes Payment for the Entirety of its 3rd Production Run of its Gelatin Free, CBD Infused Gum Drop Product, Branded as:...
View original post here: Oyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare Conference
Recent Comments